Trials / Completed
CompletedNCT00280618
Oxaliplatin in Unresectable Hepatocellular Carcinoma
Phase II Study of Eloxatin + 5-Fluorouracil/Leucovorin in Patients With Unresectable Hepatocellular Carcinoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Primary: * To determine the Tumor Response Rate of patients with hepatocellular carcinoma treated with the combination chemotherapy of Eloxatin+5-Fluorouracil/Leucovorin Secondary: * Safety and tolerability of this regimen in these patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxaliplatin |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2006-11-01
- First posted
- 2006-01-23
- Last updated
- 2009-09-15
Source: ClinicalTrials.gov record NCT00280618. Inclusion in this directory is not an endorsement.